This study tests a new drug called mitazalimab combined with standard chemotherapy for people with metastatic pancreatic cancer that has spread. The goal is to see if the combination is safe and can shrink tumors. About 94 adults who have not had prior chemotherapy for this cance…
Phase: PHASE1, PHASE2 • Sponsor: Alligator Bioscience AB • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC